Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $48.6 million.

  • Enanta Pharmaceuticals' Total Current Liabilities fell 1560.79% to $48.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year decrease of 1560.79%. This contributed to the annual value of $48.6 million for FY2025, which is 1560.79% down from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Total Current Liabilities is $48.6 million, which was down 1560.79% from $44.5 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Total Current Liabilities high stood at $68.2 million for Q2 2023, and its period low was $23.0 million during Q4 2022.
  • Over the past 5 years, Enanta Pharmaceuticals' median Total Current Liabilities value was $44.5 million (recorded in 2025), while the average stood at $43.2 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Total Current Liabilities plummeted by 3929.53% in 2022 and then soared by 19602.34% in 2023.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Total Current Liabilities stood at $37.9 million in 2021, then tumbled by 39.3% to $23.0 million in 2022, then surged by 171.32% to $62.4 million in 2023, then decreased by 21.4% to $49.0 million in 2024, then dropped by 1.01% to $48.6 million in 2025.
  • Its Total Current Liabilities was $48.6 million in Q3 2025, compared to $44.5 million in Q2 2025 and $45.9 million in Q1 2025.